Mutant IDH1 inhibition induces dsDNA sensing to activate tumor immunity
Science · 12.07.2024 · 385 (6705)
DOI: 10.1126/science.adl6173 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, erschienen am 12.07.2024. Verfasst von Meng-Ju Wu und 37 weiteren Autor:innen. Beteiligte Einrichtung: Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston MA, USA. Hauptthemen laut MEDLINE: Immunity, Innate, Isocitrate Dehydrogenase, Neoplasms, Immune Evasion. Die Arbeit wurde bisher 115-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Isocitrate dehydrogenase 1 ( IDH1 ) is the most commonly mutated metabolic gene across human cancers. Mutant IDH1 (mIDH1) generates the oncometabolite (R)-2-hydroxyglutarate, disrupting enzymes involved in epigenetics and other processes. A hallmark of IDH1 -mutant solid tumors is T cell exclusion, whereas mIDH1 inhibition in preclinical models restores antitumor immunity. Here, we define a cell-autonomous mechanism of mIDH1-driven immune evasion. IDH1 -mutant solid tumors show selective hypermethylation and silencing of the cytoplasmic double-stranded DNA (dsDNA) sensor CGAS , compromising innate immune signaling. mIDH1 inhibition restores DNA demethylation, derepressing CGAS and transposable element (TE) subclasses. dsDNA produced by TE-reverse transcriptase (TE-RT) activates cGAS, triggering viral mimicry and stimulating antitumor immunity. In summary, we demonstrate that mIDH1 epigenetically suppresses innate immunity and link endogenous RT activity to the mechanism of action of a US Food and Drug Administration–approved oncology drug.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston MA, USA.
- Center for Regenerative Medicine, Massachusetts General Hospital, Boston MA, USA.
- Department of Medicine, Harvard Medical School, Boston, MA, USA.
- Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA.
- Children's Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, TX, USA.
- Universite Paris-Saclay, Institut Gustave Roussy, INSERM U1015, Villejuif, France.
ORCID-Profile: Meng-Ju Wu, Hiroshi Kondo, Ashwin V Kammula, Lei Shi, Yi Xiao, Sofiene Dhiab, Qin Xu, Chloe J Slater, Omar I Avila, Joshua Merritt, Hiroyuki Kato, Jonathan Sussman, Ilaria Gritti, Yi Sun, Kira Olander, Takeshi Katsuda, Milan R Savani, Bailey C Smith, Raul Mostoslavsky, Vindhya Vijay, Yosuke Kitagawa, Hiroaki Wakimoto, Russell W Jenkins, Kathleen B Yates, Jihye Paik, Ania Tassinari, Duygu Hatice Saatcioglu, Adriana E Tron, Wilhelm Haas, Daniel Cahill, Samuel K McBrayer, Robert T Manguso, Nabeel Bardeesy
Förderung
- NCI NIH HHS
Zitieren
APA
Wu, M. J., Kondo, H., Kammula, A. V., Shi, L., Xiao, Y., Dhiab, S., Xu, Q., Slater, C. J., Avila, O. I., Merritt, J., Kato, H., Kattel, P., Sussman, J., Gritti, I., Eccleston, J., Sun, Y., Cho, H. M., Olander, K., Katsuda, T., …, & Bardeesy, N. (2024). Mutant IDH1 inhibition induces dsDNA sensing to activate tumor immunity. Science, 385(6705). https://doi.org/10.1126/science.adl6173
Vancouver
Wu MJ, Kondo H, Kammula AV, Shi L, Xiao Y, Dhiab S, et al. Mutant IDH1 inhibition induces dsDNA sensing to activate tumor immunity. Science. 2024;385(6705). doi:10.1126/science.adl6173
BibTeX
@article{Wu2024,
author = {Wu, Meng-Ju and Kondo, Hiroshi and Kammula, Ashwin V and Shi, Lei and Xiao, Yi and Dhiab, Sofiene and Xu, Qin and Slater, Chloe J and Avila, Omar I and Merritt, Joshua and Kato, Hiroyuki and Kattel, Prabhat and Sussman, Jonathan and Gritti, Ilaria and Eccleston, Jason and Sun, Yi and Cho, Hyo Min and Olander, Kira and Katsuda, Takeshi and Shi, Diana D and Savani, Milan R and Smith, Bailey C and Cleary, James M and Mostoslavsky, Raul and Vijay, Vindhya and Kitagawa, Yosuke and Wakimoto, Hiroaki and Jenkins, Russell W and Yates, Kathleen B and Paik, Jihye and Tassinari, Ania and Saatcioglu, Duygu Hatice and Tron, Adriana E and Haas, Wilhelm and Cahill, Daniel and McBrayer, Samuel K and Manguso, Robert T and Bardeesy, Nabeel},
title = {Mutant IDH1 inhibition induces dsDNA sensing to activate tumor immunity},
journal = {Science},
year = {2024},
volume = {385},
number = {6705},
doi = {10.1126/science.adl6173}
}
EUVIMED